Literature DB >> 33479623

New chemical agents based on adamantane-monoterpene conjugates against orthopoxvirus infections.

Evgenii V Suslov1, Evgenii S Mozhaytsev1, Dina V Korchagina1, Nikolay I Bormotov2, Olga I Yarovaya1,3, Konstantin P Volcho1,3, Olga A Serova2, Alexander P Agafonov2, Rinat A Maksyutov2, Larisa N Shishkina2, Nariman F Salakhutdinov1,3.   

Abstract

Currently, the spectrum of agents against orthopoxviruses, in particular smallpox, is very narrow. Despite the fact that smallpox is well controlled, there is, for many reasons, a real threat of epidemics associated with this or a similar virus. In order to search for new low molecular weight orthopoxvirus inhibitors, a series of amides combining adamantane and monoterpene moieties were synthesized using 1- and 2-adamantanecarboxylic acids as well as myrtenic, citronellic and camphorsulfonic acids as acid components. The produced compounds exhibited high activity against the vaccinia virus (an enveloped virus belonging to the poxvirus family), which was combined with low cytotoxicity. Some compounds had a selectivity index higher than that of the reference drug cidofovir; the highest SI = 1123 was exhibited by 1-adamantanecarboxylic acid amide containing the (-)-10-amino-2-pinene moiety. The produced compounds demonstrated inhibitory activity against other orthopoxviruses: cowpox virus (SI = 30-406) and ectromelia virus (mousepox virus, SI = 39-707). This journal is © The Royal Society of Chemistry 2020.

Entities:  

Year:  2020        PMID: 33479623      PMCID: PMC7651861          DOI: 10.1039/d0md00108b

Source DB:  PubMed          Journal:  RSC Med Chem        ISSN: 2632-8682


  23 in total

1.  [Synthesis and antiviral effects of adamantan derivatives].

Authors:  G May; D Peteri
Journal:  Arzneimittelforschung       Date:  1973-05

2.  Synthesis and antiviral activity of camphor-based 1,3-thiazolidin-4-one and thiazole derivatives as Orthopoxvirus-reproduction inhibitors.

Authors:  Anastasiya S Sokolova; Olga I Yarovaya; Nikolay I Bormotov; Larisa N Shishkina; Nariman F Salakhutdinov
Journal:  Medchemcomm       Date:  2018-09-19       Impact factor: 3.597

3.  [Antiviral agents. 24. 4(-2-Adamantyl)thiosemicarbazone].

Authors:  A Kreutzberger; H H Schröders; J Stratmann
Journal:  Arch Pharm (Weinheim)       Date:  1984-09       Impact factor: 3.751

Review 4.  Human monkeypox: an emerging zoonosis.

Authors:  Daniel B Di Giulio; Paul B Eckburg
Journal:  Lancet Infect Dis       Date:  2004-01       Impact factor: 25.071

5.  Highly potent activity of isopulegol-derived substituted octahydro-2H-chromen-4-ols against influenza A and B viruses.

Authors:  Irina V Ilyina; Vladimir V Zarubaev; Irina N Lavrentieva; Anna A Shtro; Iana L Esaulkova; Dina V Korchagina; Sophia S Borisevich; Konstantin P Volcho; Nariman F Salakhutdinov
Journal:  Bioorg Med Chem Lett       Date:  2018-04-24       Impact factor: 2.823

6.  Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox - an animal model of smallpox.

Authors:  Scott Parker; Nanhai G Chen; Scott Foster; Hollyce Hartzler; Ed Hembrador; Dennis Hruby; Robert Jordan; Randall Lanier; George Painter; Wesley Painter; John E Sagartz; Jill Schriewer; R Mark Buller
Journal:  Antiviral Res       Date:  2012-02-18       Impact factor: 10.103

7.  Development of ST-246® for Treatment of Poxvirus Infections.

Authors:  Robert Jordan; Janet M Leeds; Shanthakumar Tyavanagimatt; Dennis E Hruby
Journal:  Viruses       Date:  2010-11-03       Impact factor: 5.818

Review 8.  Tecovirimat: First Global Approval.

Authors:  Sheridan M Hoy
Journal:  Drugs       Date:  2018-09       Impact factor: 11.431

9.  Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments.

Authors:  Ryan S Noyce; Seth Lederman; David H Evans
Journal:  PLoS One       Date:  2018-01-19       Impact factor: 3.240

Review 10.  Human Monkeypox: Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention.

Authors:  Eskild Petersen; Anu Kantele; Marion Koopmans; Danny Asogun; Adesola Yinka-Ogunleye; Chikwe Ihekweazu; Alimuddin Zumla
Journal:  Infect Dis Clin North Am       Date:  2019-04-11       Impact factor: 5.905

View more
  3 in total

1.  Novel Tdp1 Inhibitors Based on Adamantane Connected with Monoterpene Moieties via Heterocyclic Fragments.

Authors:  Aldar A Munkuev; Evgenii S Mozhaitsev; Arina A Chepanova; Evgeniy V Suslov; Dina V Korchagina; Olga D Zakharova; Ekaterina S Ilina; Nadezhda S Dyrkheeva; Alexandra L Zakharenko; Jóhannes Reynisson; Konstantin P Volcho; Nariman F Salakhutdinov; Olga I Lavrik
Journal:  Molecules       Date:  2021-05-24       Impact factor: 4.411

2.  Synthesis, structure, and antiviral properties of novel 2-adamantyl-5-aryl-2H-tetrazoles.

Authors:  Olga V Mikolaichuk; Vladimir V Zarubaev; Anna А Muryleva; Yana L Esaulkova; Daria V Spasibenko; Alina А Batyrenko; Ilya V Kornyakov; Rostislav Е Trifonov
Journal:  Chem Heterocycl Compd (N Y)       Date:  2021-05-26       Impact factor: 1.277

3.  Adamantane derivatives as potential inhibitors of p37 major envelope protein and poxvirus reproduction. Design, synthesis and antiviral activity.

Authors:  Vadim A Shiryaev; Michael Yu Skomorohov; Marina V Leonova; Nikolai I Bormotov; Olga A Serova; Larisa N Shishkina; Alexander P Agafonov; Rinat A Maksyutov; Yuri N Klimochkin
Journal:  Eur J Med Chem       Date:  2021-04-29       Impact factor: 7.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.